Skip to content

Prevention of Lymphoceles After Robotic PLND

A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02035475
Acronym
PLND
Enrollment
120
Registered
2014-01-14
Start date
2014-08-31
Completion date
2014-12-31
Last updated
2016-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoceles, Prostate Cancer

Keywords

Prevention, Pelvic Lymph Node Dissection, Lymphoceles, Prostate Malignancies, daVinci, Vessel Sealer, EndoWrist One

Brief summary

The EndoWrist One Vessel Sealer is a bipolar electrosurgical instrument for use with the da Vinci Si robotic surgical system. It is intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit within the jaws of the instrument. Their use in this study will be to perform tissue transection during PLND such that the intended use is within the FDA-approved domain for this instrument. Investigators intend to identify whether its use for PLND reduces lymphoceles given that the device is known to seal vessels up to 7 mm, which is much larger than lymphatic vessels encountered during PLND. Because the instrument is new and has been FDA approved for less than one year, there is no published literature regarding its use to date. Our hypothesis is that using the Vessel Sealer on a single side of the pelvis will reduce the incidence of screening detected lymphoceles on that side. Investigators propose a total sample size of 120 patients.

Detailed description

Investigators propose a prospective, randomized, single-blinded study of patients diagnosed with pelvic cancer who are electing to undergo robotic surgery with PLND. The patients in our trial will be pelvic cancer patients at risk for lymphocele after PLND. Given the safe nature of the product and the patient's risk for lymphocele after PLND and subsequent potential morbidity, there is justification to give patients the option for inclusion in the study. Investigators intend to determine whether the rate of lymphocele formation after PLND at the time of robotic pelvic cancer surgery can be reduced by using the robotic Vessel Sealer unilaterally for the lymph node dissection. The side of the pelvis of each patient will be randomly selected by Excel's® random number function RAND() to receive the Vessel Sealer dissection. Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control and eliminate patient specific confounding variables such as BMI, and surgeon specific factors such as degree and method of hemostasis utilized by each surgeon. In addition, Dr. Abaza will be the only surgeon performing these procedures, eliminating variation in technique between surgeons.

Interventions

DEVICEIntuitive Vessel Sealer

Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.

Sponsors

Intuitive Surgical
CollaboratorINDUSTRY
OhioHealth
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Candidate scheduled to undergo robotic prostatectomy surgery with PLND

Exclusion criteria

* Age \< 18 * Unable to give informed consent * Non-English speaking * Not a candidate for robotic surgery for any reason

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Lymphoceles4 monthsIdentify whether the use of the Vessel Sealer for PLND reduces the incidence of screening detected lymphoceles via CT scan of the pelvis by comparing the Vessel Sealer side of the pelvis with the control side of the pelvis.

Secondary

MeasureTime frameDescription
Surgical Complications4 monthsEvaluate perioperative and postoperative surgical outcomes at 4 months after surgery. Possible outcomes include no complications (0), minor complications (1), and major complications (2).

Countries

United States

Participant flow

Recruitment details

Prostatectomy patients were recruited from a single robotic urologists office, between 1/15/13 and 5/12/14. The final followup visit was completed on 12/18/14.

Pre-assignment details

Participants must be eligible for robotic procedures.

Participants by arm

ArmCount
Intuitive Vessel Sealer
Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control. Intuitive Vessel Sealer: Investigators intend to use this device unilaterally so the contralateral side can serve as an internal control.
114
Total114

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyEquipment Error1
Overall StudyPhysician Decision1
Overall StudyWithdrawal by Subject4

Baseline characteristics

CharacteristicIntuitive Vessel Sealer
Age, Continuous62.2 years
STANDARD_DEVIATION 7.4
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
114 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 114
serious
Total, serious adverse events
3 / 114

Outcome results

Primary

Incidence of Lymphoceles

Identify whether the use of the Vessel Sealer for PLND reduces the incidence of screening detected lymphoceles via CT scan of the pelvis by comparing the Vessel Sealer side of the pelvis with the control side of the pelvis.

Time frame: 4 months

Population: Lymphoceles were identified by CT scan at 3 months post surgery.

ArmMeasureGroupValue (NUMBER)
EndoWrist 1 Vessel SealerIncidence of LymphocelesLymphoceles10 participants
EndoWrist 1 Vessel SealerIncidence of LymphocelesNo Lymphoceles104 participants
Fenestrated Maryland BiPolar InstrumentIncidence of LymphocelesLymphoceles12 participants
Fenestrated Maryland BiPolar InstrumentIncidence of LymphocelesNo Lymphoceles102 participants
Comparison: The null hypothesis is that there is no difference in the incidence of detected lymphoceles whether the EndoWrist 1 Vessel Sealer or the Fenestrated Maryland BiPolar Instrument were used.p-value: 0.412McNemar
Secondary

Surgical Complications

Evaluate perioperative and postoperative surgical outcomes at 4 months after surgery. Possible outcomes include no complications (0), minor complications (1), and major complications (2).

Time frame: 4 months

ArmMeasureValue (NUMBER)
EndoWrist 1 Vessel SealerSurgical Complications3 participants

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026